Abdelgani S, Khattab A, Adams J, Abu-Farha M, et al. Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients. Diabetes Care 2023;46:978-984.
PMID: 36857415